Usefulness of plasma B-type natriuretic peptide in predicting recurrence of atrial fibrillation one year after external cardioversion.
After successful external cardioversion, the rate of recurrence of atrial fibrillation remains high. The hypothesis that plasma B-type natriuretic peptide could predict the recurrence of atrial fibrillation at 1 year was tested. Plasma B-type natriuretic peptide was measured in 66 consecutive asymptomatic patients who underwent external cardioversion for atrial fibrillation. Twelve-lead electrocardiograms were obtained at 1 year. Sinus rhythm was maintained in 55% of patients. The independent predictors of the recurrence of atrial fibrillation at 1 year were a history of atrial fibrillation, plasma B-type natriuretic peptide, and the energy delivered for conversion. In patients without symptoms of heart failure, plasma B-type natriuretic peptide is an independent predictor of the recurrence of atrial fibrillation.
Lellouche
Nicolas
N
Fédération de Cardiologie, Hôpital de Jour, Henri Mondor University Hospital, Créteil, France.
Berthier
Romain
R
Mekontso-Dessap
Armand
A
Braconnier
François
F
Monin
Jean-Luc
JL
Duval
Anne-Marie
AM
Dubois-Randé
Jean Luc
JL
Guéret
Pascal
P
Garot
Jérôme
J
D000368:Aged; D001281:Atrial Fibrillation / Q000097:blood / Q000503:physiopathology / Q000628:therapy*; D015415:Biomarkers / Q000097:blood*; D004554:Electric Countershock; D004562:Electrocardiography; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D020097:Natriuretic Peptide, Brain / Q000097:blood*; D012008:Recurrence
D015415:Biomarkers; D020097:Natriuretic Peptide, Brain